Exane Derivatives’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-243
Closed -$16.8K 686
2016
Q4
$16.8K Sell
243
-750
-76% -$52.1K ﹤0.01% 379
2016
Q3
$71.6K Sell
993
-1,400
-59% -$103K 0.01% 267
2016
Q2
$172K Buy
2,393
+200
+9% +$14.1K 0.03% 212
2016
Q1
$149K Buy
2,193
+1,128
+106% +$75.6K 0.02% 213
2015
Q4
$76.7K Sell
1,065
-2,772
-72% -$196K 0.01% 234
2015
Q3
$254K Buy
3,837
+1,655
+76% +$121K 0.03% 168
2015
Q2
$162K Sell
2,182
-3,439
-61% -$255K 0.02% 221
2015
Q1
$408K Buy
5,621
+474
+9% +$33.8K 0.05% 157
2014
Q4
$352K Buy
+5,147
New +$345K 0.05% 166

Other funds holding XLV

Exane Derivatives's XLV Position: Q1 2017 in Review

Exane Derivatives sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2017, closing a stake of 243 shares — an estimated $16.8K sold.

Exane Derivatives first reported a position in XLV in Q4 2014 and held it in 9 quarters. The position peaked at $408K in Q1 2015. 660 funds tracked by Wall St. Rank hold XLV as of Q1 2017.

  • Exane Derivatives reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 243 State Street Health Care Select Sector SPDR ETF shares in Q1 2017, an estimated $16.8K.
  • Exane Derivatives first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's State Street Health Care Select Sector SPDR ETF position peaked at $408K in Q1 2015.
  • 660 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.